We're a growth-oriented biopharmaceutical company improving patient lives by developing and commercializing advanced products across a range of therapies.
View Top Employees from Xeris Pharmaceuticals, Inc.Website | http://www.xerispharma.com |
Ticker | XERS |
Revenue | $2 million |
Funding | $483.4 million |
Employees | 386 (386 on RocketReach) |
Founded | 2005 |
Address | 180 N. Lasalle, Chicago, Illinois 60601, US |
Phone | (512) 498-2670 |
Technologies |
JavaScript,
HTML,
Google Analytics
+40 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Pharmaceuticals, Healthcare |
Keywords | Therapeutic Activities, Biopharmaceuticals, Advanced Therapies, Innovative Pharmaceutical Company, Specialty Pharmaceutical, Healthcare Products, Pharmaceutical Therapies, Pharmaceutical Innovation |
Competitors | PolyPid Ltd., Presidio Pharmaceuticals, Inc., TARIS Bio, Urigen Pharmaceuticals, Inc., UroGen Pharma (formerly TheraCoat) |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular Xeris Pharmaceuticals, Inc. employee's phone or email?
The Xeris Pharmaceuticals, Inc. annual revenue was $2 million in 2024.
Steven Pieper is the CFO of Xeris Pharmaceuticals, Inc..
386 people are employed at Xeris Pharmaceuticals, Inc..
Xeris Pharmaceuticals, Inc. is based in Chicago, Illinois.
The NAICS codes for Xeris Pharmaceuticals, Inc. are [32541, 325, 3254, 32].
The SIC codes for Xeris Pharmaceuticals, Inc. are [283, 28].